Nuo Therapeutics, Inc. (NASDAQOTH:NUOT)

CAPS Rating: 3 out of 5

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.


Player Avatar Zippidy1 (99.62) Submitted: 12/13/2007 2:12:09 PM : Underperform Start Price: $3.30 NUOT Score: +69.87

I have to hand it to them, they fought the FDA all the way to a clearance for their AutoloGel. It has potential as a good product but it's a one product company that is barely on the market. I just can't see them holding on to a $3+ share price for long.

Featured Broker Partners